SCHEMBL273074

SCHEMBL273074

C=Cc1ccc(OC)c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.54
LMNA P02545 2/20 0.54
IDO1 P14902 1/20 0.52
IMPDH2 P12268 1/20 0.52
IMPDH1 P20839 1/20 0.52
EP300 Q09472 1/20 0.50
KAT8 Q9H7Z6 1/20 0.50
CAPN1 P07384 1/20 0.48
CTSL P07711 1/20 0.48
CTSB P07858 1/20 0.48
ABCB1 P08183 1/20 0.48
MEN1 O00255 2/20 0.47
HPGD P15428 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CHAT P28329 1/20 0.46
NQO1 P15559 1/20 0.45
GCGR P47871 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29600672 1.00 MAPT (0.54) MAPTLMNAIDO1IMPDH2IMPDH1
SCHEMBL3627384 0.88 TLR2 (0.43) MAPTLMNAIDO1IMPDH2IMPDH1
SCHEMBL7915395 0.80 MAPT (0.63) MAPTLMNAIDO1IMPDH2IMPDH1
SCHEMBL7915398 0.80 MAPT (0.63) MAPTLMNAIDO1IMPDH2IMPDH1
SCHEMBL545661 0.80 MAPT (0.54) MAPTLMNAIDO1IMPDH2IMPDH1
SCHEMBL29708066 0.80 MAPT (0.54) MAPTLMNAIDO1IMPDH2IMPDH1
SCHEMBL29380721 0.80 IDO1 (0.73) MAPTLMNAIDO1IMPDH2IMPDH1
SCHEMBL29434197 0.80 ALDH1A1 (0.48) MAPTLMNAIDO1MEN1HPGD
SCHEMBL419307 0.80 IDO1 (0.73) MAPTLMNAIDO1IMPDH2IMPDH1
SCHEMBL2100602 0.80 ALDH1A1 (0.48) MAPTLMNAIDO1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 580 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4744902-A1 ON-PRESS DEVELOPMENT-TYPE PLANOGRAPHIC PRINTING PLATE PRECURSOR, PLANOGRAPHIC PRINTING PLATE PRODUCTION METHOD, AND PLANOGRAPHIC PRINTING METHO FUJIFILM Corporation (JP) 2026-05-20 EP disclosed
EP-4744901-A1 ON-PRESS DEVELOPMENT TYPE PLANOGRAPHIC PRINTING PLATE ORIGINAL PLATE, METHOD FOR PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING METHOD, AND COMPOUND FUJIFILM Corporation (JP) 2026-05-20 EP disclosed
US-20260131566-A1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD FUJIFILM CORPORATION (JP) 2026-05-14 US disclosed
US-20260131567-A1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, LITHOGRAPHIC PRINTING METHOD, AND COMPOUND FUJIFILM CORPORATION (JP) 2026-05-14 US disclosed
EP-4223538-B1 INKJET RECORDING METHOD FUJIFILM CORP (JP) 2026-04-15 EP disclosed
EP-4223537-B1 INK-JET INK AND INK-JET RECORDING METHOD FUJIFILM CORP (JP) 2026-04-15 EP disclosed
EP-4036123-B1 PARTICLE, AQUEOUS DISPERSION, INK JET INK, FILM-FORMING METHOD, AND IMAGE-FORMING METHOD FUJIFILM CORP (JP) 2026-04-01 EP disclosed
EP-4186708-B1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING A LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD FUJIFILM CORP (JP) 2026-03-04 EP disclosed
EP-4693286-A1 PHOTOSENSITIVE COMPOSITION FOR HOLOGRAM RECORDING, HOLOGRAM RECORDING MEDIUM, POLYMER, LARGE CAPACITY MEMORY, OPTICAL ELEMENT, AR LIGHT GUIDE PLATE, AND AR GLASSES Mitsubishi Chemical Corporation (JP) 2026-02-11 EP disclosed
EP-4692042-A1 COMPOUND, POLYMERIZABLE COMPOSITION, HOLOGRAM RECORDING MEDIUM, POLYMER, OPTICAL MATERIAL, AND OPTICAL COMPONENT Mitsubishi Chemical Corporation (JP) 2026-02-11 EP disclosed
US-5112929-A Reaction of dienes to produce polymers with 1,2-microstructure BRIDGESTONE CORPORATION (JP) 1992-05-12 US disclosed
EP-0476640-A1 High performance tire treads and tires Bridgestone Corporation (JP) 1992-03-25 EP disclosed
EP-0476662-A1 Ultra high molecular weight copolymers of conjugated dienes and aromatic vinyl compounds BRIDGESTONE/FIRESTONE, INC. (US) 1992-03-25 EP disclosed
EP-0476665-A1 Oil extended ultra high molecular weight elastomers BRIDGESTONE CORPORATION (JP) 1992-03-25 EP disclosed
EP-0476641-A1 Ultra high molecular weight elastomer composition BRIDGESTONE CORPORATION (JP) 1992-03-25 EP disclosed
US-4591624-A LITHIUM INITIATOR; CYCLIC ACETAL OF A GLYOXAL AND OPTIONALLY ORGANO MAGNESIUM OR ORGANOLALUMINUM COINITIATOR THE FIRESTONE TIRE & RUBBER COMPANY (US) 1986-05-27 US disclosed
EP-0171497-A1 Catalyst system and process for polymerizing conjugated dienes THE FIRESTONE TIRE & RUBBER COMPANY (US) 1986-02-19 EP disclosed
US-4520123-A LITHIUM INITIATOR AND MODIFIER COMPRISING A CYCLIC ACETAL OF A GLYOXAL THE FIRESTONE TIRE & RUBBER COMPANY (US) 1985-05-28 US disclosed
US-4039593-A CAPPING ORGANO-DILITHIUM POLYMERS, N,N,N*,N*-TETRAMETHYLENEDIAMINE ON LITHIUM CORPORATION OF AMERICA (US) 1977-08-02 US disclosed
US-3954894-A Organotrilithium polymerization initiators LITHIUM CORPORATION OF AMERICA (US) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260131567-A1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, LITHOGRAPHIC PRINTING METHOD, AND COMPOUND LEF1, LARP1, RUVBL1 MAPT 3559/4885LMNA 220/4885IDO1 2877/4885
US-20260131566-A1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD LAMTOR3, LEF1, RER1 MAPT 2846/4885LMNA 173/4885IDO1 4243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.